Mercer Global Advisors Inc Repligen Corp Transaction History

Mercer Global Advisors Inc

  • $43 Billion
  • Q1 2025

A detailed history of Mercer Global Advisors Inc transactions in Repligen Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 1,741 shares of RGEN stock, worth $220,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,741
Previous 1,855 6.15%
Holding current value
$220,584
Previous $267,000 17.23%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$127.24 - $174.24 $14,505 - $19,863
-114 Reduced 6.15%
1,741 $221,000
Q4 2024

Feb 14, 2025
SELL
$123.41 - $160.92 $128,222 - $167,195
-1,039 Reduced 35.9%
1,855 $267,000
Q3 2024

Nov 13, 2024
BUY
$119.79 - $167.35 $25,754 - $35,980
215 Added 8.03%
2,894 $430,000
Q2 2024

Aug 12, 2024
SELL
$120.0 - $182.95 $20,160 - $30,735
-168 Reduced 5.9%
2,679 $337,000
Q1 2024

May 15, 2024
BUY
$170.78 - $208.42 $133,720 - $163,192
783 Added 37.94%
2,847 $524,000
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $7,192 - $11,677
-63 Reduced 2.96%
2,064 $371,000
Q3 2023

Nov 13, 2023
SELL
$138.78 - $176.51 $212,749 - $270,589
-1,533 Reduced 41.89%
2,127 $338,000
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $43,879 - $57,158
317 Added 9.48%
3,660 $517,000
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $30,080 - $38,629
195 Added 6.19%
3,343 $562,000
Q4 2022

Feb 08, 2023
SELL
$162.42 - $220.56 $188,894 - $256,511
-1,163 Reduced 26.98%
3,148 $533,000
Q3 2022

Nov 15, 2022
BUY
$160.42 - $256.21 $62,082 - $99,153
387 Added 9.86%
4,311 $807,000
Q2 2022

Aug 10, 2022
SELL
$140.68 - $188.02 $122,391 - $163,577
-870 Reduced 18.15%
3,924 $637,000
Q1 2022

May 10, 2022
BUY
$161.19 - $257.96 $36,590 - $58,556
227 Added 4.97%
4,794 $902,000
Q4 2021

Feb 04, 2022
BUY
$247.59 - $304.47 $124,537 - $153,148
503 Added 12.38%
4,567 $1.21 Million
Q3 2021

Nov 10, 2021
SELL
$194.77 - $324.21 $14,997 - $24,964
-77 Reduced 1.86%
4,064 $1.17 Million
Q2 2021

Aug 10, 2021
SELL
$165.87 - $220.95 $35,496 - $47,283
-214 Reduced 4.91%
4,141 $827,000
Q1 2021

May 11, 2021
SELL
$180.37 - $226.26 $167,563 - $210,195
-929 Reduced 17.58%
4,355 $847,000
Q4 2020

Feb 12, 2021
BUY
$148.08 - $206.57 $268,469 - $374,511
1,813 Added 52.23%
5,284 $1.01 Million
Q3 2020

Dec 10, 2020
BUY
$122.51 - $158.27 $25,604 - $33,078
209 Added 6.41%
3,471 $512,000
Q2 2020

Aug 10, 2020
BUY
$94.33 - $140.48 $48,485 - $72,206
514 Added 18.7%
3,262 $403,000
Q1 2020

May 18, 2020
BUY
$84.96 - $109.14 $8,326 - $10,695
98 Added 3.7%
2,748 $265,000
Q4 2019

Feb 13, 2020
BUY
$73.84 - $93.08 $195,676 - $246,662
2,650 New
2,650 $245,000

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
57.6M
Call Options Held
75.6K
Put Options Held
521K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.03B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email